Clinical Research

Introduction                                     

In advancing cancer immunotherapy, antibodies against PD-1 have become a breakthrough and opened a new door for severely affected cancer patients. Nevertheless, the results of preclinical studies have faced various obstacles in transforming into successful clinical...